Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Alliances symbols : JNJ save search
Merck Bets Potential $1B on Pearl Bio’s Genomically Recoded Organisms
Published: 2024-03-12 (Crawled : 17:00) - biospace.com/
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 1.12%
H: 0.0%
C: 0.0%
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
merck potential
AstraZeneca to Spend $247M in Collaboration with AI Discovery Outfit Absci
Published: 2023-12-04 (Crawled : 16:00) - biospace.com/
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 0.98%
H: 0.0%
C: 0.0%
astrazeneca collaboration
J&J’s Christopher Whelan on How—and Why—13 Companies Teamed up to Tackle Prot...
Published: 2023-10-18 (Crawled : 05:00) - biospace.com/
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: -0.83%
H: 0.35%
C: -1.72%
companies
Sandoz to Commercialize Samsung Bioepis’ Biosimilar to J&J’s Stelara
Published: 2023-09-12 (Crawled : 13:30) - biospace.com/
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 0.62%
H: 0.0%
C: 0.0%
biosimilar stelara
Week in Review: Licensing Deals, M&A, EU Regulators on a Tear, Latest in IRA ...
Published: 2023-07-14 (Crawled : 21:00) - biospace.com/
PRGO A | $30.15 0.07% 400K
|
Health Technology
|
| O: 4.6%
H: 0.66%
C: -2.13%
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 0.23%
H: 0.66%
C: 0.43%
week
Janssen Enters Worldwide Collaboration and License Agreement with Cellular Biomedicine Group to Develop Next Generation CAR-T Therapies
Published: 2023-05-02 (Crawled : 16:00) - biospace.com/
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 0.45%
H: 0.69%
C: 0.42%
license group collaboration car-t agreement
ClearPoint Neuro Announces Agreement with NE Scientific to Integrate Gene Therapy Infusion Coverage Tool into ClearPoint Maestro® Brain Model
Published: 2023-04-18 (Crawled : 00:00) - biospace.com/
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: -0.86%
H: 0.27%
C: -1.97%
CLPT | $5.7 1.6% 45K
|
Health Technology
|
| O: 0.0%
H: 4.06%
C: 2.22%
maestro agreement therapy
Pipeline Therapeutics Announces Global License and Development Agreement for Investigational Neuroscience Therapy, PIPE-307
Published: 2023-04-17 (Crawled : 14:00) - biospace.com/
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: -0.06%
H: 0.3%
C: -0.04%
pipe-307 license pipeline global therapeutics agreement
Biocytogen Announces RenLite® Licensing Agreement with Janssen
Published: 2023-03-08 (Crawled : 14:00) - biospace.com/
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: -0.07%
H: 0.14%
C: -0.66%
renlite agreement
Protagonist Therapeutics Announces Positive Topline Results for Phase 2b FRONTIER 1 Clinical Trial of Oral IL-23 Receptor Antagonist JNJ-2113 (PN-235) in Psoriasis
Published: 2023-03-07 (Crawled : 14:00) - biospace.com/
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 0.34%
H: 0.1%
C: -1.28%
PTGX | $26.06 -1.96% 95K
|
Health Technology
|
| O: 11.64%
H: 39.6%
C: 36.06%
il-23 topline trial therapeutics psoriasis frontier positive
The Bristol Myers Squibb-Janssen Collaboration Launches Pivotal Phase 3 Librexia Clinical Trial Program Evaluating Milvexian, an Investigational Oral Factor XIa Inhibitor
Published: 2023-03-02 (Crawled : 14:00) - biospace.com/
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: -0.54%
H: 0.67%
C: 0.46%
BMY | $48.365 -0.3% 4.9M
|
Health Technology
|
| O: -0.19%
H: 0.72%
C: -0.06%
collaboration program trial
Ankyra Therapeutics Announces Collaboration to Evaluate ANK-101 in Early Clinical Trials Focused on Lung Cancer
Published: 2023-02-07 (Crawled : 14:00) - biospace.com/
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: -1.08%
H: 1.41%
C: 1.11%
ank-101 lung trials collaboration therapeutics cancer
Hebrew University' Yissum and Israeli Biotech Clearmind Medicine’s Psychedelic-Derived Obesity Treatment Presented by Professor Joseph Tam, D.M.D., Ph.D. at Isranalytica 2023
Published: 2023-01-25 (Crawled : 15:20) - biospace.com/
CMND | $1.255 34K
|
n/a
|
| O: 6.31%
H: 12.35%
C: -7.36%
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: -0.68%
H: 1.4%
C: 1.4%
treatment obesity biotech
Fate Ends Potential $3B Janssen Partnership
Published: 2023-01-06 (Crawled : 16:00) - biospace.com/
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 0.74%
H: 0.44%
C: 0.07%
partnership potential
Pfizer and Roivant Launch Another Vant with an Initial Focus on Ulcerative Co...
Published: 2022-12-01 (Crawled : 17:00) - biospace.com/
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 0.56%
H: 0.54%
C: -0.15%
ulcerative colitis
HDT Bio Selected to Join BLUE KNIGHT™
Published: 2022-11-07 (Crawled : 12:00) - biospace.com/
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 0.58%
H: 0.0%
C: 0.0%
blue
J&J Expands Cardiovascular Business with $16.6B Abiomed Acquisition
Published: 2022-11-01 (Crawled : 15:00) - biospace.com/
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: -0.36%
H: 0.0%
C: 0.0%
acquisition cardiovascular
Sonnet BioTherapeutics Announces an Agreement with Janssen for the Evaluation of Three Sonnet Product Candidates
Published: 2022-10-31 (Crawled : 14:20) - biospace.com/
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: -0.08%
H: 0.0%
C: 0.0%
SONN | $2.0 7.9K
|
Health Technology
|
| O: 18.97%
H: 95.65%
C: 39.86%
agreement
Sanofi and BioMed X Partner to Predict Efficacy with Virtual Patient Populati...
Published: 2022-10-24 (Crawled : 18:00) - biospace.com/
SNYNF | $92.966 630
|
Health Technology
|
| O: 2.37%
H: 0.29%
C: 0.29%
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 3.52%
H: 0.0%
C: 0.0%
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: 1.94%
H: 0.0%
C: 0.0%
sanofi
Merck Joins Accumulus Synergy as a Sponsor to Transform the Global Drug Regulatory Submission Process
Published: 2022-09-20 (Crawled : 14:00) - biospace.com/
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: -0.33%
H: 0.0%
C: 0.0%
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: -1.18%
H: 0.0%
C: 0.0%
drug global submission
Gainers vs Losers
| 53% | 47% |
Top 10 Gainers
WISA 4 | $7.86 349.14% 120M
|
Electronic Technology
TPET | $0.4951 114.24% 29M
|
n/a
PRSO | $1.99 56.69% 52M
|
Manufacturing
PALI | $6.5 56.25% 22M
|
Manufacturing
JAGX | $0.1767 48.74% 430M
|
Health Technology
SXTC | $2.03 45.0% 27M
|
Health Technology
SPCB | $0.3888 40.87% 27M
|
Electronic Technology
DYNT | $0.52 40.39% 20M
|
Health Technology
SNGX | $0.54 39.86% 7.3M
|
Health Technology
BSGM | $1.53 39.09% 2.6M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.